# ANDEMBRY

NDC: 63833-925
Generic name: Garadacimab
Labeler / Manufacturer: CSL
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20250616

FDA application: BLA761367

## Active ingredients

- GARADACIMAB: 200 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63833-925"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63833-925
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=07b0b671-db81-49f0-a402-0c0219db7fa2